Millrace Asset Group Inc. reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 6.2% in the 3rd quarter, Holdings Channel reports. The firm owned 32,847 shares of the exchange traded fund’s stock after selling 2,165 shares during the period. SPDR S&P Biotech ETF makes up 3.3% of Millrace Asset Group Inc.’s holdings, making the stock its biggest holding. Millrace Asset Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,245,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in XBI. Tidemark LLC raised its holdings in shares of SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after buying an additional 199 shares during the last quarter. ORG Partners LLC acquired a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $40,000. Quintet Private Bank Europe S.A. acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $40,000. ORG Wealth Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $44,000. Finally, Howe & Rusling Inc. acquired a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $49,000.
SPDR S&P Biotech ETF Price Performance
SPDR S&P Biotech ETF stock opened at $97.63 on Tuesday. The business has a 50 day simple moving average of $98.37 and a 200-day simple moving average of $96.38. SPDR S&P Biotech ETF has a 12 month low of $71.99 and a 12 month high of $105.47. The stock has a market capitalization of $7.44 billion, a PE ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Stocks That Authorized $1 Billion Stock Buybacks to Boost Value
- What does consumer price index measure?
- Pure Storage’s GenAI Pods and AI Trends Could Spark Recovery
- Investing In Automotive Stocks
- Is Seaboard Corporation a Thanksgiving Feast for Investors?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.